Reckitt Benckiser to feel pain of GSK's costs in Nurofen case

Reckitt Benckiser to feel pain of GSK’s costs in Nurofen case

Competition & Consumer Protection 2018-02-28 3:47 pm By Christine Caulfield | Melbourne

Please login to bookmark

Reckitt Benckiser has been ordered to pay all of GlaxoSmithKline’s legal bill after a judge found the drug giant misled consumers with claims that Nurofen was a more effective pain killer than its rival’s Panadol.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au